Important Takeaways:
- Some staff members at the Food and Drug Administration are considering a quick exit as Robert F. Kennedy Jr. is being floated as a potential health official in the incoming Trump administration, according to three former and one current government official who were granted anonymity to speak freely about sensitive issues. The former officials are still in touch with colleagues who work at the FDA.
- Staff turnover is typical when a new administration comes in, and a significant number of FDA employees similarly considered leaving before President-elect Donald Trump’s first term in office, said one former and one current official. At the time, there were also concerns about what the FDA would look like under the first Trump administration.
- This time, however, there’s an added layer of anxiety outside Trump: Kennedy.
- Trump has said he’ll let the former independent presidential candidate and vaccine skeptic “go wild on health.” Meanwhile, Kennedy is promising a shakeup at the federal health agencies, including the FDA, telling NBC News the day after the election that “in some categories, there are entire departments, like the nutrition department at the FDA that are, that have to go.”
Read the original article by clicking here.
Important Takeaways:
- Seventy Americans in one state are being monitored for bird flu due to potential exposure – after FDA said H5N1 could trigger pandemic
- The dairy farm workers are being monitored in Colorado as of May 6
- Details about their ages, gender and conditions have not been revealed, but they all worked on a farm in the northeastern part of the state.
- Only one person so far – a farmer in Texas – has tested positive for H5N1 virus this outbreak, but the CDC fears many more could be infected and not coming forward.
- It comes as the FDA’s top official revealed the agency is gearing up for a bird flu pandemic in people that could kill one in four of those it infects.
Read the original article by clicking here.
Important Takeaways:
- ‘WHITE LUNG’ Comes to America as Drug Shortages Grow
- A “mysterious Chinese pneumonia,” termed “White Lung” by the clever pundits on the evening news, is making headlines as it rolls through schools and homes across the United States.
- As the fear-mongering escalates, many Americans recall a lesson from the last pandemic: the FDA demonized and blocked access to important medications like Ivermectin.
- Pharmaceutical shortages and bans are real. And it’s happening again.
- The cures for sicknesses like this new pneumonia are nothing revolutionary. The only thing standing between many Americans and health could be our own government.
- That’s why it pays to be prepared ahead of time.
- Drew Pinsky, world-renowned doctor at The Wellness Company, explains: “White Lung” is a sensational name for these pneumonia infections seen this winter in the United States. This outbreak seems to be the result of RSV, Influenza, and most likely common Mycoplasma. The first line of Mycoplasma treatment for adults is Azithromycin (Z-pak) — a core life-saving medicine found in our Medical Emergency Kits. Having a kit on hand is an ideal way to be prepared for the first sign of a Mycoplasma [pneumonia] infection.
- Don’t rely on Joe Biden’s healthcare system to have your back.
- Whether the crisis comes in the form of a new pneumonia or something more mundane like a tick bite – you and your family need to be prepared.
Read the original article by clicking here.
Important Takeaways:
- FDA advisers discuss future of ‘artificial womb’ for human infants
- Independent advisers to the U.S. Food and Drug Administration are meeting this week to discuss the regulations, ethics and possibilities of creating an artificial womb to increase the chances that extremely premature babies would survive — and without long-term health problems.
- Although no such device has been tested in humans, similar ones have been used in a handful of cases to successfully develop animals
- An artificial womb is not designed to replace a pregnant person; it could not be used from conception until birth. Rather, it could be used to help a small number of infants born before 28 weeks of pregnancy, which is considered extreme prematurity.
- “We believe that our preclinical data supports feasibility and safety and that it’s adequate for consideration of a carefully designed clinical study of artificial womb technology,” Flake told the committee.
Read the original article by clicking here.
Luke 21:11 There will be great earthquakes, and in various places famines and pestilences. And there will be terrors and great signs from heaven.
Important Takeaways:
- CDC confirms heart disease risk soars 13,200 percent among vaccinated
- A bombshell study from the U.S. Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) has confirmed that the risk of autoimmune heart disease is 13,200% higher in people who are vaccinated for Covid.
- The study found that the risk of myocarditis following mRNA Covid vaccination is around 133x greater than the background risk in the population.
- The study’s authors used data obtained from the CDC’s VAERS reporting system.
- The data was then cross-checked to ensure the results complied with the CDC’s definition of myocarditis.
- The researchers also noted that given the passive nature of the VAERS system, the number of reported incidents is likely to be an underestimate of the extent of the phenomenon.
- 1626 cases of myocarditis were studied.
- The results showed that the Pfizer-BioNTech product was most associated with higher risk.
- The Pfizer jabs caused 105.9 cases per million doses after the second vaccine shot in the 16 to 17 age group for males.
- In the 12 to 15 age group for males, 70.7 cases per million doses were recorded after the second shot.
- The 18 to 24 male age group also saw significantly higher rates of myocarditis for both Pfizer’s (52.4 cases per million) and Moderna’s (56.3 cases per million) products.
- Researchers also noted that 82 percent of cases were in males, consistent with previous studies.
- The risk was highest after the second vaccination dose in adolescent males and young men.
Read the original article by clicking here.
Revelations 18:23:’For the merchants were the great men of the earth; for by thy sorceries were all nations deceived.’
Important Takeaways:
- U.S. is running out of common children’s antibiotic amoxicillin – forcing parents to shop around multiple pharmacies
- Four Drugmakers behind nearly the entire country’s supply are facing a shortage
- The liquid form of the medication is in short supply, they said
- Officials made aware last month when patients struggled to fill prescriptions
- The Food and Drug Association (FDA) blamed a surge in demand for the shortage — with respiratory illnesses at unseasonably high levels.
- Amoxicillin is a common antibiotic prescribed to children to treat ear and sinus infections.
Read the original article by clicking here.
Rev 6:6 NAS “And I heard something like a voice in the center of the four living creatures saying, “A quart of wheat for a denarius, and three quarts of barley for a denarius; and do not damage the oil and the wine.”
Important Takeaways:
- ISRAELI FIRM COMMITS TO SHIPPING 200,000 CANS OF BABY FORMULA TO US TO HELP SOLVE CRISIS
- An Israeli-based company hopes to fill the void
- Three weeks ago, the U.S. Food and Drug Administration issued emergency guidance enabling the import of infant formulas produced abroad.
- Tel Aviv-based MyOr—an Israeli health-tech company—is among companies seeking FDA approval as its Mexican subsidiary, AlphaCare, produces and markets MyOr formulas from a plant in north-central Mexico.
- “We have 200,000 cans of formula ready to be shipped right now, with a capacity to produce another 250,000 a month,” said MyOr co-founder and chief technology officer Michael Brandwein.
- Founded in 2018, MyOr provides preventive health-care solutions for infants at-risk with a specific focus on food allergies and nutritional sufficiency.
Read the original article by clicking here.
Rev 6:6 NAS And I heard something like a voice in the center of the four living creatures saying, “A quart of wheat for a denarius, and three quarts of barley for a denarius; and do not damage the oil and the wine.”
Important Takeaways:
- 114 drugs currently in shortage, per FDA
- Nationwide, more than 100 drugs are in short supply, including antibiotics, diuretics, opioids and heart failure medications, FDA data shows.
- The most recent drug added to the FDA’s shortage list was heparin sodium and sodium chloride 0.9 percent injection, an anticoagulant, on Jan. 7. Dexmedetomidine injection, a sedative used for patients on ventilators, was added Dec. 27, 2021.
- View the entire list here https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
Read the original article by clicking here.
Rev 6:6 NAS And I heard something like a voice in the center of the four living creatures saying, “A quart of wheat for a denarius, and three quarts of barley for a denarius; and do not damage the oil and the wine.”
Important Takeaways:
- Gary Cohn, then chief economic advisor to President Trump, argued against a trade war with China by invoking a Department of Commerce study that found that 97 percent of all antibiotics in the United States came from China. “If you’re the Chinese and you want to really just destroy us, just stop sending us antibiotics,” he said.
- If we are dependent on China for thousands of ingredients and raw materials to make our medicine, China could use this dependence as a weapon against us.
Read the original article by clicking here.
(Reuters) – The U.S. Food and Drug Administration classified the recall of Ellume’s over-the-counter COVID-19 home test as Class 1, the most serious type of recall, after the Australian diagnostic test maker removed some of its tests from the market last month.
Ellume had cited higher-than-acceptable false positive test results for SARS-CoV-2 as the reason for the recall.
A ‘false positive’ indicates that a person has the virus when they actually do not.
The antigen test, which detects proteins from the SARS-CoV-2 virus from a nasal sample, is available without a prescription for use by people above two years of age with or without COVID-19 symptoms.
The agency said on Wednesday there have been 35 complaints of the antigen test giving false positive results, but no death had been reported related to the test.
Ellume has so far recalled 2,212,335 tests in the United States.
(Reporting by Mrinalika Roy in Bengaluru; Editing by Shinjini Ganguli)
